Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 389.1M | 290.5M | 50.7M | 0 | 0 | 0 |
| Gross Profit | 366.1M | 270.5M | 47.6M | 0 | 0 | — |
| Profitability | ||||||
| Operating Income | 161.3M | 103.2M | -97.2M | -120.2M | -68.3M | -33.0M |
| EBITDA | 167.8M | 147.4M | -69.6M | -112.3M | -66.2M | -30.3M |
| Net Income | 204.8M | 89.2M | 10.9M | -140.0M | -69.6M | -32.2M |
| Per Share Data | ||||||
| EPS (diluted) | $6.84 | $3.00 | $0.39 | $-5.49 | $-3.13 | $-1.71 |
| Shares Outstanding (dil.) | 29M | 29M | 27M | 25M | 22M | 19M |
Krystal Biotech Inc. Income Statement — FAQ
Krystal Biotech Inc. (KRYS) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRYS's income statement history?
The chart and table above show Krystal Biotech Inc.'s income statement by year and by quarter, including the growth rate.